UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4), p.e94892-e94892

2014

Link zum Volltext

Verfügbarkeit prüfen

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors

PloS one, 2012-02, Vol.7 (2), p.e31420-e31420

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1624

2014

Link zum Volltext

Verfügbarkeit prüfen

Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.(Research Article)

PloS one, 2016-12, Vol.11 (12), p.e0168210

2016

Link zum Volltext

Verfügbarkeit prüfen

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides

PloS one, 2013, Vol.8 (9), p.e73648-e73648

2013

Link zum Volltext

Verfügbarkeit prüfen

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Critical care (London, England), 2008-01, Vol.12 (3), p.R83-R83

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (17), p.1874

2011

Link zum Volltext

Verfügbarkeit prüfen

MHC Class II Tetramers Made from Isolated Recombinant [alpha] and [beta] Chains Refolded with Affinity-Tagged Peptides.(Research Article)

PloS one, 2013-09, Vol.8 (9), p.e73648

2013

Link zum Volltext

Verfügbarkeit prüfen

A non‐fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-05, Vol.121 (5), p.456-459

2013

Link zum Volltext

Verfügbarkeit prüfen

Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

European journal of haematology, 2012-08, Vol.89 (2), p.151-159

2012

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

European journal of haematology, 2001-02, Vol.66 (2), p.73-82

Vindelov, Lars

2001

Link zum Volltext

Verfügbarkeit prüfen

A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

Experimental hematology, 2003-10, Vol.31 (10), p.855-864

2003

Link zum Volltext

Verfügbarkeit prüfen

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

PloS one, 2016-12, Vol.11 (12), p.e0168210-e0168210

2016

Link zum Volltext

Verfügbarkeit prüfen

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (12), p.1556-1560

2016

Link zum Volltext

Verfügbarkeit prüfen

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-02, Vol.110 (2), p.148-157

2002

Link zum Volltext

Verfügbarkeit prüfen

Association of HMGB1 Polymorphisms with Outcome after Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2010-02, Vol.16 (2), p.239-252

2010

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Blood, 2014-12, Vol.124 (21), p.1176-1176

2014

Link zum Volltext

Verfügbarkeit prüfen

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-12, Vol.8 (12)

2013

Link zum Volltext

Verfügbarkeit prüfen

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-09, Vol.8 (9)

2013

Link zum Volltext

Verfügbarkeit prüfen

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4)

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Blood, 2012-11, Vol.120 (21), p.3098-3098

2012

Link zum Volltext

Verfügbarkeit prüfen

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

American journal of hematology, 2008-07, Vol.83 (7), p.563-569

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(59)
Science & Technology
(49)
Life Sciences & Biomedicine
(46)
Biological And Medical Sciences
(30)
Medical Sciences
(29)
Male
(26)
Female
(25)
Hematology
(23)
Animals
(22)
Middle Aged
(22)
Flow Cytometry
(21)
Mice
(18)
Adult
(17)
Aged
(15)
Transplantation, Homologous
(15)
Antineoplastic Agents
(14)
Pharmacology. Drug Treatments
(14)
Immunology
(13)
Oncology
(13)
Carcinoma, Small Cell - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.(Research Article)

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

MHC Class II Tetramers Made from Isolated Recombinant [alpha] and [beta] Chains Refolded with Affinity-Tagged Peptides.(Research Article)

A non‐fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient

Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

Association of HMGB1 Polymorphisms with Outcome after Allogeneic Hematopoietic Cell Transplantation

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

Suchergebnisse filtern